Skip to main content
. 2019 Nov 20;11(12):1824. doi: 10.3390/cancers11121824

Figure 3.

Figure 3

Survival of HCC patients with high and low number or quality of predicted neoantigens in the validation set, considering the value in the I and the III quartiles (A,C,E) as well as the value below and above the mean (B,D,F). Neoantigens: overall predicted neoantigens (A,B). Neoantigens DAI > 10: predicted neoantigens with a differential agretopicity index (DAI) > 10 compared to the corresponding wild type epitope (C,D). Neoantigens DAI > 10; affinity < 50 nM: predicted neoantigens as before, with a value of affinity < 50 nM (E,F).